About Emocog
Emocog is a company based in Seoul (South Korea) by Jun Young Lee and Yoo Hun Noh. Emocog has raised $15 million across 1 funding round from investors including Industrial Bank of Korea, KB Investment and Stonebridge Capital. Emocog offers products and services including Cogthera, 기억콕콕, CAT, CLT, and NeuLearn. Emocog operates in a competitive market with competitors including Lumosity, Peak, Intellect, Elevate and BrainHQ, among others.
- Headquarter Seoul, South Korea
- Founders Jun Young Lee, Yoo Hun Noh
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aunt Cog Co., Ltd.
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series B
Dec 27, 2024
-
Investors
Industrial Bank of Korea
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Emocog
Emocog offers a comprehensive portfolio of products and services, including Cogthera, 기억콕콕, CAT, CLT, and NeuLearn.
Software for mild cognitive impairment treatment and monitoring.
Mobile app for quick dementia risk evaluation and brain health advice.
Web-based tool for evaluating attention deficits in children and adults.
Platform for early detection of dyslexia and dyscalculia in students.
App that uses brain science to assist with vocabulary memorization.
Funding Insights of Emocog
Emocog has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Emocog
Emocog has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Industrial Bank of Korea, KB Investment and Stonebridge Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech and life sciences focused VC & PE firm
|
Locked | Locked | Locked | |
|
Provider of a venture capital firm for various sectors
|
Locked | Locked | Locked | |
|
Venture capital fund investing in early-stage tech startups
|
Locked | Locked | Locked |
Investor details for Emocog
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Emocog
Investment portfolio details for Emocog
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Emocog
Detailed financials for Emocog
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emocog Comparisons
Peer comparison for Emocog
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Emocog
Emocog operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lumosity, Peak, Intellect, Elevate and BrainHQ, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Brain training games for web and apps are developed.
|
|
| Locked | Locked | Locked |
Peak is recognized for developing brain training mobile applications.
|
|
| Locked | Locked | Locked |
Integrated mental healthcare solutions are provided for workforces.
|
|
| Locked | Locked | Locked |
Brain training games are developed for cognitive skill enhancement.
|
|
| Locked | Locked | Locked |
Online brain exercises for cognitive aging and conditions are provided.
|
|
| Locked | Locked | Locked |
Neuroscience-based brain training games are provided by Memorado.
|
Detailed competitors of Emocog
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emocog
Complete news archive for Emocog
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emocog
Emocog is headquartered in Seoul, South Korea.
Jun Young Lee is the current CEO of Emocog. They have also founded this company.
Emocog is a funded company, having raised a total of $15M across 1 funding round to date.
Developer of digital therapeutics for cognitive impairment. It develops and provides software medical devices for the assessment and treatment of cognitive decline, focusing on mild cognitive impairment (MCI) and related conditions. The company offers a suite of digital tools, including mobile applications and web-based platforms, designed to aid in early detection, diagnosis, and management of cognitive issues. These solutions utilize AI-powered personalized interventions to improve cognitive function and support patients throughout their care journey. A key product is a software medical device for MCI cognitive improvement. The company also offers solutions for learning disabilities.
Emocog offers Cogthera, 기억콕콕, CAT, CLT, and NeuLearn.
Emocog has 5 investors. Key investors include Industrial Bank of Korea, KB Investment, Stonebridge Capital, Shinhan Venture Investment, and Envisioning Partners.